In the U.S., growth will be influenced by the adoption of products that have only been available overseas, preference for motion-preserving technologies over fusion, and challenges with respect to reimbursement and coverage. In Europe, where aging populations will contribute to the demand for small joint implants, cost-containment efforts will influence prices and product purchases. AP and ROW countries feature differences in disease prevalence, demographics, and processes for reimbursement, regulatory approval, and product distribution.
This report examines the market for replacement, fixation, and fusion implants for the shoulder, elbow, wrist, fingers, ankle and foot, and provides a detailed analysis of the clinical and economic factors driving regional markets.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
